Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 900

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 infection

Open access
Diao, Bo, Wang, Chenhui, Wang, Rongshuai, Feng, Zeqing, Zhang, Ji, Yang, Han, Tan, Yingjun, Wang, Huiming, Wang, Changsong, Liu, Liang, Liu, Ying, Liu, Yueping, Wang, Gang, Yuan, Zilin, Hou, Xiaotao, Ren, Liang, Wu, Yuzhang, Chen, Yongwen·2021·Nature Communications

Published version of a preprint

Abstract

It is unclear whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can directly infect human kidney, thus leading to acute kidney injury (AKI). Here, we perform a retrospective analysis of clinical parameters from 85 patients with laboratory-confirmed coronavirus disease 2019 (COVID-19); moreover, kidney histopathology from six additional COVID-19 patients with post-mortem examinations was performed. We find that 27% (23/85) of patients exhibited AKI. The elderly patients and cases with comorbidities (hypertension and heart failure) are more prone to develop AKI. Haematoxylin & eosin staining shows that the kidneys from COVID-19 autopsies have moderate to severe tubular damage. In situ hybridization assays illustrate that viral RNA accumulates in tubules. Immunohistochemistry shows nucleocapsid and spike protein deposits in the tubules, and immunofluorescence double staining shows that both antigens are restricted to the angiotensin converting enzyme-II-positive tubules. SARS-CoV-2 infection triggers the expression of hypoxic damage-associated molecules, including DP2 and prostaglandin D synthase in infected tubules. Moreover, it enhances CD68+ macrophages infiltration into the tubulointerstitium, and complement C5b-9 deposition on tubules is also observed. These results suggest that SARS-CoV-2 directly infects human kidney to mediate tubular pathogenesis and AKI.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-021-22781-1

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 38

  1. Lu, R. et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet https://doi.org/10.1016/S0140-6736(20)30251-8 (2020). · DOI · Paper page
  2. Bernard, S. S. et al. First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020. Euro surveill. 25, 2000094 (2020). · DOI · Paper page
  3. Cheng, S.-C. et al. First case of Coronavirus Disease 2019 (COVID-19) pneumonia in Taiwan. J. Formos. Med. Assoc. 119, 747–751 (2020). · DOI · Paper page
  4. Wang, D. et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA, https://doi.org/10.1001/jama.2020.1585 (2020). · DOI · Paper page
  5. Xu, X. W. et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ 368, m606 (2020). · DOI · Paper page
  6. Zhang, J. J. et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy, https://doi.org/10.1111/all.14238 (2020). · DOI · Paper page
  7. Xu, X. et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci. China Life Sci. 63, 457–460 (2020). · DOI · Paper page
  8. Chan, J. F.-W. et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg. Microbes Infect. 9, 221–236 (2020). · DOI · Paper page
  9. Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature https://doi.org/10.1038/s41586-020-2012-7 (2020). · DOI · Paper page
  10. Lin, W. et al. Single-cell analysis of ACE2 expression in human kidneys and bladders reveals a potential route of 2019-nCoV Infection. bioRxiv. Preprint at https://doi.org/10.1101/2020.02.08.939892 (2020). · DOI
  11. Fan, C., Li, K., Ding, Y., Lu, W. L. & Wang, J. ACE2 expression in kidney and testis may cause kidney and testis damage after 2019-nCoV infection. medRxiv. Preprint at https://doi.org/10.1101/2020.02.12.20022418 (2020). · DOI
  12. Cheng Y. et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 97, 829–838 (2020). · DOI · Paper page
  13. Kers, J., Leemans, J. C. & Linkermann, A. An overview of pathways of regulated necrosis in acute kidney injury. Semin Nephrol. 36, 139–152 (2016). · DOI · Paper page
  14. Reich, H. N., Oudit, G. Y., Penninger, J. M., Scholey, J. W. & Herzenberg, A. M. Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease. Kidney Int. 74, 1610–1616 (2008). · DOI · Paper page
  15. Sarhan, M., von Massenhausen, A., Hugo, C., Oberbauer, R. & Linkermann, A. Immunological consequences of kidney cell death. Cell Death Dis. 9, 114 (2018). · DOI
  16. Takano, T., Elimam, H. & Cybulsky, A. V. in Seminars in Nephrology, 586–601 (Elsevier).
  17. Cheng, Y. et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 97, 829–838 (2020). · DOI · Paper page
  18. Kronbichler, A. et al. COVID-19: implications for immunosuppression in kidney disease and transplantation. Nat. Rev. Nephrol, https://doi.org/10.1038/s41581-020-0305-6 (2020). · DOI
  19. Chu, K. H. et al. Acute renal impairment in coronavirus-associated severe acute respiratory syndrome. Kidney Int. 67, 698–705 (2005). · DOI · Paper page
  20. Ding, Y. et al. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS‐CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J. Pathol. 203, 622–630 (2004). · DOI · Paper page
  21. Poissy, J. et al. Kinetics and pattern of viral excretion in biological specimens of two MERS-CoV cases. J. Clin. Virol. 61, 275–278 (2014). · DOI
  22. Gu, J. et al. Multiple organ infection and the pathogenesis of SARS. J. Exp. Med. 202, 415–424 (2005). · DOI · Paper page
  23. Lang et al. A clinicopathological study of three cases of severe acute respiratory syndrome (SARS). Pathology 35, 526–531 (2003). · DOI
  24. Chu, K. H. et al. Acute renal impairment in coronavirus-associated severe acute respiratory syndrome. Kidney Int. 67, 698–705 (2005). · DOI · Paper page
  25. Chan, J. F. et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 395, 514–523 (2020). · DOI · Paper page
  26. Sun, J. et al. Isolation of infectious SARS-CoV-2 from urine of a COVID-19 patient. Emerg. Microbes Infect. 9, 991–993 (2020). · DOI · Paper page
  27. Lely, A., Hamming, I., van Goor, H. & Navis, G. Renal ACE2 expression in human kidney disease. J. Pathol. 204, 587–593 (2004). · DOI · Paper page
  28. Meng, X.-M., Nikolic-Paterson, D. J. & Lan, H. Y. Inflammatory processes in renal fibrosis. Nat. Rev. Nephrol. 10, 493–503 (2014). · DOI · Paper page
  29. Saffarzadeh, M. et al. Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones. PLoS ONE 7, e32366 (2012). · DOI · Paper page
  30. Pober, J. S. & Sessa, W. C. Inflammation and the blood microvascular system. Cold Spring Harb. Perspect. Biol. 7, a016345 (2015). · DOI · Paper page
  31. Mastellos, D. C., Ricklin, D. & Lambris, J. D. Clinical promise of next-generation complement therapeutics. Nat. Rev. Drug Disco. 18, 707–729 (2019). · DOI · Paper page
  32. Schiela, B. et al. Active Human Complement Reduces the Zika Virus Load via Formation of the Membrane-Attack Complex. Front. Immunol. 9, 2177 (2018). · DOI
  33. Gralinski, L. E. et al. Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis. mBio 9, https://doi.org/10.1128/mBio.01753-18(2018). · DOI · Paper page
  34. Biancone, L. et al. Alternative pathway activation of complement by cultured human proximal tubular epithelial cells. Kidney Int. 45, 451–460 (1994). · doi:10.1038/ki.1994.59
  35. Cybulsky, A. V. et al. Complement C5b-9 membrane attack complex increases expression of endoplasmic reticulum stress proteins in glomerular epithelial cells. J. Biol. Chem. 277, 41342–41351 (2002). · doi:10.1074/jbc.m204694200
  36. David, S. et al. Alternative pathway complement activation induces proinflammatory activity in human proximal tubular epithelial cells. Nephrol., Dialysis, Transplant. 12, 51–56 (1997). · DOI
  37. Lai, K. N., Lo, S. T. & Lai, F. M. Immunohistochemical study of the membrane attack complex of complement and S-protein in idiopathic and secondary membranous nephropathy. Am. J. Pathol. 135, 469–476 (1989).
  38. Li, J. et al. VSIG4 inhibits proinflammatory macrophage activation by reprogramming mitochondrial pyruvate metabolism. Nat. Commun. 8, 1322 (2017). · DOI · Paper page

Cited by

See all 900

Metadata

Authors
Diao, B., Wang, C., Wang, R., Feng, Z., Zhang, J., Yang, H., Tan, Y., Wang, H., Wang, C., Liu, L., Liu, Y., Liu, Y., Wang, G., Yuan, Z., Hou, X., Ren, L., Wu, Y., & Chen, Y.
Venue
Nature Communications
Published
2021-05-04
Volume
12
Issue
1
Pages
2506-2506
ISSN
2041-1723 (ISSN-L)
OpenAlex
W3157025007
Cited by
900
References
6
FWCI
42.72
Type
journal article
Language
en
Open access
gold
Licence
Funders
National Science Foundation of China | National Natural Science Foundation of China-Yunnan Joint Fund (81701551, 81971478, 81701562, 81771691)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 infection. https://app.cochat.ai/papers/10.1038/s41467-021-22781-1
The paper
Diao, B., Wang, C., Wang, R., Feng, Z., Zhang, J., Yang, H., Tan, Y., Wang, H., Wang, C., Liu, L., Liu, Y., Liu, Y., Wang, G., Yuan, Z., Hou, X., Ren, L., Wu, Y., & Chen, Y. (2021). Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 infection. Nature Communications. https://doi.org/10.1038/s41467-021-22781-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.